Antileishmanial agent-13
Antileishmanial agent-13 is a quinoline-isatin hybrid, acts as an antileishmanial agent against L. Major Leishmania strain. Antileishmanial agent-13 acquires the antileishmanial activity via the anti-folate mechanism. Antileishmanial agent-13 has potent inhibition against both promastigote and amastigote forms with IC50s of 0.604 μM and 0.508 μM, respectively[1].
Product Specifications
CAS Number
[853725-86-7]
UNSPSC
12352005
Target
Parasite
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/antileishmanial-agent-13.html
Solubility
10 mM in DMSO
Smiles
O=C1NC2=C(/C1=N\NC3=CC=NC4=CC(Cl)=CC=C43)C=C(C=C2)Br
Molecular Formula
C17H10BrClN4O
Molecular Weight
401.64
References & Citations
[1]Sabt A, et al. New antileishmanial quinoline linked isatin derivatives targeting DHFR-TS and PTR1: Design, synthesis, and molecular modeling studies[J]. European Journal of Medicinal Chemistry, 2022: 114959.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Leishmania
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
035071-AP 200 µL
ENDOD1, ID (ENDOD1, KIAA0830, Endonuclease domain-containing 1 protein) (AP) discontinued
Ask
View Details 
MBS1289116-01 0.02 mg (E-Coli)
Recombinant Symbiobacterium thermophilum Elongation factor P (efp)
Ask
View Details